Andreia Gameiro - Search Results

Year	Number of Results
2014	1
2016	1
2018	1
2020	1
2021	7
2022	0

1

Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma.

Gameiro A, Urbano AC, Ferreira F. Gameiro A, et al. Vet Sci. 2021 Aug 11;8(8):164. doi: 10.3390/vetsci8080164. Vet Sci. 2021. PMID: 34437486 Free PMC article. Review.

2

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma.

Nascimento C, Gameiro A, Ferreira J, Correia J, Ferreira F. Nascimento C, et al. Among authors: gameiro a. Cancers (Basel). 2021 Jan 1;13(1):117. doi: 10.3390/cancers13010117. Cancers (Basel). 2021. PMID: 33401382 Free PMC article.

3

Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma.

Gameiro A, Almeida F, Nascimento C, Correia J, Ferreira F. Gameiro A, et al. Pharmaceutics. 2021 Mar 6;13(3):346. doi: 10.3390/pharmaceutics13030346. Pharmaceutics. 2021. PMID: 33800900 Free PMC article.

4

Histone Deacetylase Inhibitors and Microtubule Inhibitors Induce Apoptosis in Feline Luminal Mammary Carcinoma Cells.

Almeida F, Gameiro A, Correia J, Ferreira F. Almeida F, et al. Among authors: gameiro a. Animals (Basel). 2021 Feb 15;11(2):502. doi: 10.3390/ani11020502. Animals (Basel). 2021. PMID: 33671894 Free PMC article.

5

HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models.

Gameiro A, Nascimento C, Correia J, Ferreira F. Gameiro A, et al. Cancers (Basel). 2021 Apr 21;13(9):2007. doi: 10.3390/cancers13092007. Cancers (Basel). 2021. PMID: 33919468 Free PMC article.

6

Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes.

Gameiro A, Nascimento C, Urbano AC, Correia J, Ferreira F. Gameiro A, et al. Front Vet Sci. 2021 Feb 10;8:625147. doi: 10.3389/fvets.2021.625147. eCollection 2021. Front Vet Sci. 2021. PMID: 33644151 Free PMC article.

7

VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes.

Gameiro A, Nascimento C, Correia J, Ferreira F. Gameiro A, et al. Cancers (Basel). 2021 Nov 5;13(21):5559. doi: 10.3390/cancers13215559. Cancers (Basel). 2021. PMID: 34771722 Free PMC article.

8

Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes.

Nascimento C, Urbano AC, Gameiro A, Ferreira J, Correia J, Ferreira F. Nascimento C, et al. Among authors: gameiro a. Cancers (Basel). 2020 May 28;12(6):1386. doi: 10.3390/cancers12061386. Cancers (Basel). 2020. PMID: 32481540 Free PMC article.

9

CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors.

Marques CS, Santos AR, Gameiro A, Correia J, Ferreira F. Marques CS, et al. Among authors: gameiro a. BMC Cancer. 2018 Jul 16;18(1):741. doi: 10.1186/s12885-018-4650-9. BMC Cancer. 2018. PMID: 30012106 Free PMC article.

10

Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.

Soares M, Ribeiro R, Najmudin S, Gameiro A, Rodrigues R, Cardoso F, Ferreira F. Soares M, et al. Among authors: gameiro a. Oncotarget. 2016 Apr 5;7(14):17314-26. doi: 10.18632/oncotarget.7551. Oncotarget. 2016. PMID: 26909614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results